✦ LIBER ✦

ChemInform Abstract: Discovery of Lu AA33810: A Highly and Potent NPY5 Antagonist with in vivo Efficacy in a Model of Mood Disorder.

✍ Scribed by Mathivanan Packiarajan; et al. et al.

Book ID: 102066014
Publisher: John Wiley and Sons
Year: 2011
Weight: 21 KB
Volume: 43
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.201201202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Lu AA33810: A highly select

Discovery of Lu AA33810: A highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder

✍ Mathivanan Packiarajan; Mohammad R. Marzabadi; Mahesh Desai; Yalei Lu; Stewart A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1004 KB

ChemInform Abstract: Discovery, Oral Pha

ChemInform Abstract: Discovery, Oral Pharmacokinetics and in vivo Efficacy of a Highly Selective 5-HT 4 Receptor Agonist: Clinical Compound TD-2749.

✍ Long, Daniel D.; et al., et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB

ChemInform Abstract: Discovery of an Imi

ChemInform Abstract: Discovery of an Imidazopyridine-Containing 1,4-Benzodiazepine Nonpeptide Vitronectin Receptor (αvβ3) Antagonist with Efficacy in a Restenosis Model.

✍ Richard M. Keenan; M. Amparo Lago; William H. Miller; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

Discovery of an Imidazopyridine-Containing 1,4-Benzodiazepine Nonpeptide Vitronectin Receptor (αvβ3) Antagonist with Efficacy in a Restenosis Model. -Among a variety of title compounds of type (I) and (II) the derivative (II) has sufficient potency and in vivo pharmacokinetics for demonstration of e